Global Multiple Myeloma Drugs Market 2017: Industry, Sales, Demand, Analysis, Opportunities and Forecast to 2022

 Published: Jun-2018 |  Format: PDF | Qy Research |  Number of pages: 105

<pre>This report studies Multiple Myeloma Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Amgen Johnson & Johnson Celgene Takeda Pharmaceutical Novartis Daiichi Sankyo Merck AB Science Teva PharmaMar On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Immunomodulatory drugs (IMiDs) Proteasome inhibitors Chemotherapy Histone deacetylase inhibitor (HDAC inhibitor) Steroids (corticosteroids) By Application, the market can be split into Men Women By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India If you have any special requirements, please let us know and we will offer you the report as you want.</pre>
<pre>Table of Contents Global Multiple Myeloma Drugs Market Professional Survey Report 2018 1 Industry Overview of Multiple Myeloma Drugs 1.1 Definition and Specifications of Multiple Myeloma Drugs 1.1.1 Definition of Multiple Myeloma Drugs 1.1.2 Specifications of Multiple Myeloma Drugs 1.2 Classification of Multiple Myeloma Drugs 1.2.1 Immunomodulatory drugs (IMiDs) 1.2.2 Proteasome inhibitors 1.2.3 Chemotherapy 1.2.4 Histone deacetylase inhibitor (HDAC inhibitor) 1.2.5 Steroids (corticosteroids) 1.3 Applications of Multiple Myeloma Drugs 1.3.1 Men 1.3.2 Women 1.3.3 Application 3 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 2 Manufacturing Cost Structure Analysis of Multiple Myeloma Drugs 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Multiple Myeloma Drugs 2.3 Manufacturing Process Analysis of Multiple Myeloma Drugs 2.4 Industry Chain Structure of Multiple Myeloma Drugs 3 Technical Data and Manufacturing Plants Analysis of Multiple Myeloma Drugs 3.1 Capacity and Commercial Production Date of Global Multiple Myeloma Drugs Major Manufacturers in 2017 3.2 Manufacturing Plants Distribution of Global Multiple Myeloma Drugs Major Manufacturers in 2017 3.3 R&D Status and Technology Source of Global Multiple Myeloma Drugs Major Manufacturers in 2017 3.4 Raw Materials Sources Analysis of Global Multiple Myeloma Drugs Major Manufacturers in 2017 4 Global Multiple Myeloma Drugs Overall Market Overview 4.1 2013-2018E Overall Market Analysis 4.2 Capacity Analysis 4.2.1 2013-2018E Global Multiple Myeloma Drugs Capacity and Growth Rate Analysis 4.2.2 2017 Multiple Myeloma Drugs Capacity Analysis (Company Segment) 4.3 Sales Analysis 4.3.1 2013-2018E Global Multiple Myeloma Drugs Sales and Growth Rate Analysis 4.3.2 2017 Multiple Myeloma Drugs Sales Analysis (Company Segment) 4.4 Sales Price Analysis 4.4.1 2013-2018E Global Multiple Myeloma Drugs Sales Price 4.4.2 2017 Multiple Myeloma Drugs Sales Price Analysis (Company Segment) 5 Multiple Myeloma Drugs Regional Market Analysis 5.1 North America Multiple Myeloma Drugs Market Analysis 5.1.1 North America Multiple Myeloma Drugs Market Overview 5.1.2 North America 2013-2018E Multiple Myeloma Drugs Local Supply, Import, Export, Local Consumption Analysis 5.1.3 North America 2013-2018E Multiple Myeloma Drugs Sales Price Analysis 5.1.4 North America 2017 Multiple Myeloma Drugs Market Share Analysis 5.2 China Multiple Myeloma Drugs Market Analysis 5.2.1 China Multiple Myeloma Drugs Market Overview 5.2.2 China 2013-2018E Multiple Myeloma Drugs Local Supply, Import, Export, Local Consumption Analysis 5.2.3 China 2013-2018E Multiple Myeloma Drugs Sales Price Analysis 5.2.4 China 2017 Multiple Myeloma Drugs Market Share Analysis 5.3 Europe Multiple Myeloma Drugs Market Analysis 5.3.1 Europe Multiple Myeloma Drugs Market Overview 5.3.2 Europe 2013-2018E Multiple Myeloma Drugs Local Supply, Import, Export, Local Consumption Analysis 5.3.3 Europe 2013-2018E Multiple Myeloma Drugs Sales Price Analysis 5.3.4 Europe 2017 Multiple Myeloma Drugs Market Share Analysis 5.4 Southeast Asia Multiple Myeloma Drugs Market Analysis 5.4.1 Southeast Asia Multiple Myeloma Drugs Market Overview 5.4.2 Southeast Asia 2013-2018E Multiple Myeloma Drugs Local Supply, Import, Export, Local Consumption Analysis 5.4.3 Southeast Asia 2013-2018E Multiple Myeloma Drugs Sales Price Analysis 5.4.4 Southeast Asia 2017 Multiple Myeloma Drugs Market Share Analysis 5.5 Japan Multiple Myeloma Drugs Market Analysis 5.5.1 Japan Multiple Myeloma Drugs Market Overview 5.5.2 Japan 2013-2018E Multiple Myeloma Drugs Local Supply, Import, Export, Local Consumption Analysis 5.5.3 Japan 2013-2018E Multiple Myeloma Drugs Sales Price Analysis 5.5.4 Japan 2017 Multiple Myeloma Drugs Market Share Analysis 5.6 India Multiple Myeloma Drugs Market Analysis 5.6.1 India Multiple Myeloma Drugs Market Overview 5.6.2 India 2013-2018E Multiple Myeloma Drugs Local Supply, Import, Export, Local Consumption Analysis 5.6.3 India 2013-2018E Multiple Myeloma Drugs Sales Price Analysis 5.6.4 India 2017 Multiple Myeloma Drugs Market Share Analysis 6 Global 2013-2018E Multiple Myeloma Drugs Segment Market Analysis (by Type) 6.1 Global 2013-2018E Multiple Myeloma Drugs Sales by Type 6.2 Different Types of Multiple Myeloma Drugs Product Interview Price Analysis 6.3 Different Types of Multiple Myeloma Drugs Product Driving Factors Analysis 6.3.1 Immunomodulatory drugs (IMiDs) of Multiple Myeloma Drugs Growth Driving Factor Analysis 6.3.2 Proteasome inhibitors of Multiple Myeloma Drugs Growth Driving Factor Analysis 6.3.3 Chemotherapy of Multiple Myeloma Drugs Growth Driving Factor Analysis 6.3.4 Histone deacetylase inhibitor (HDAC inhibitor) of Multiple Myeloma Drugs Growth Driving Factor Analysis 6.3.5 Steroids (corticosteroids) of Multiple Myeloma Drugs Growth Driving Factor Analysis 7 Global 2013-2018E Multiple Myeloma Drugs Segment Market Analysis (by Application) 7.1 Global 2013-2018E Multiple Myeloma Drugs Consumption by Application 7.2 Different Application of Multiple Myeloma Drugs Product Interview Price Analysis 7.3 Different Application of Multiple Myeloma Drugs Product Driving Factors Analysis 7.3.1 Men of Multiple Myeloma Drugs Growth Driving Factor Analysis 7.3.2 Women of Multiple Myeloma Drugs Growth Driving Factor Analysis 8 Major Manufacturers Analysis of Multiple Myeloma Drugs 8.1 Amgen 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Product A 8.1.2.2 Product B 8.1.3 Amgen 2017 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Amgen 2017 Multiple Myeloma Drugs Business Region Distribution Analysis 8.2 Johnson & Johnson 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Product A 8.2.2.2 Product B 8.2.3 Johnson & Johnson 2017 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Johnson & Johnson 2017 Multiple Myeloma Drugs Business Region Distribution Analysis 8.3 Celgene 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Product A 8.3.2.2 Product B 8.3.3 Celgene 2017 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Celgene 2017 Multiple Myeloma Drugs Business Region Distribution Analysis 8.4 Takeda Pharmaceutical 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Product A 8.4.2.2 Product B 8.4.3 Takeda Pharmaceutical 2017 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Takeda Pharmaceutical 2017 Multiple Myeloma Drugs Business Region Distribution Analysis 8.5 Novartis 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Product A 8.5.2.2 Product B 8.5.3 Novartis 2017 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Novartis 2017 Multiple Myeloma Drugs Business Region Distribution Analysis 8.6 Daiichi Sankyo 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Product A 8.6.2.2 Product B 8.6.3 Daiichi Sankyo 2017 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Daiichi Sankyo 2017 Multiple Myeloma Drugs Business Region Distribution Analysis 8.7 Merck 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Product A 8.7.2.2 Product B 8.7.3 Merck 2017 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 Merck 2017 Multiple Myeloma Drugs Business Region Distribution Analysis 8.8 AB Science 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.2.1 Product A 8.8.2.2 Product B 8.8.3 AB Science 2017 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 AB Science 2017 Multiple Myeloma Drugs Business Region Distribution Analysis 8.9 Teva 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.2.1 Product A 8.9.2.2 Product B 8.9.3 Teva 2017 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Teva 2017 Multiple Myeloma Drugs Business Region Distribution Analysis 8.10 PharmaMar 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.2.1 Product A 8.10.2.2 Product B 8.10.3 PharmaMar 2017 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 PharmaMar 2017 Multiple Myeloma Drugs Business Region Distribution Analysis 9 Development Trend of Analysis of Multiple Myeloma Drugs Market 9.1 Global Multiple Myeloma Drugs Market Trend Analysis 9.1.1 Global 2018-2025 Multiple Myeloma Drugs Market Size (Volume and Value) Forecast 9.1.2 Global 2018-2025 Multiple Myeloma Drugs Sales Price Forecast 9.2 Multiple Myeloma Drugs Regional Market Trend 9.2.1 North America 2018-2025 Multiple Myeloma Drugs Consumption Forecast 9.2.2 China 2018-2025 Multiple Myeloma Drugs Consumption Forecast 9.2.3 Europe 2018-2025 Multiple Myeloma Drugs Consumption Forecast 9.2.4 Southeast Asia 2018-2025 Multiple Myeloma Drugs Consumption Forecast 9.2.5 Japan 2018-2025 Multiple Myeloma Drugs Consumption Forecast 9.2.6 India 2018-2025 Multiple Myeloma Drugs Consumption Forecast 9.3 Multiple Myeloma Drugs Market Trend (Product Type) 9.4 Multiple Myeloma Drugs Market Trend (Application) 10 Multiple Myeloma Drugs Marketing Type Analysis 10.1 Multiple Myeloma Drugs Regional Marketing Type Analysis 10.2 Multiple Myeloma Drugs International Trade Type Analysis 10.3 Traders or Distributors with Contact Information of Multiple Myeloma Drugs by Region 10.4 Multiple Myeloma Drugs Supply Chain Analysis 11 Consumers Analysis of Multiple Myeloma Drugs 11.1 Consumer 1 Analysis 11.2 Consumer 2 Analysis 11.3 Consumer 3 Analysis 11.4 Consumer 4 Analysis 12 Conclusion of the Global Multiple Myeloma Drugs Market Professional Survey Report 2017 Methodology Analyst Introduction Data Source List of Tables and Figures Figure Picture of Multiple Myeloma Drugs Table Product Specifications of Multiple Myeloma Drugs Table Classification of Multiple Myeloma Drugs Figure Global Production Market Share of Multiple Myeloma Drugs by Type in 2017 Figure Immunomodulatory drugs (IMiDs) Picture Table Major Manufacturers of Immunomodulatory drugs (IMiDs) Figure Proteasome inhibitors Picture Table Major Manufacturers of Proteasome inhibitors Figure Chemotherapy Picture Table Major Manufacturers of Chemotherapy Figure Histone deacetylase inhibitor (HDAC inhibitor) Picture Table Major Manufacturers of Histone deacetylase inhibitor (HDAC inhibitor) Figure Steroids (corticosteroids) Picture Table Major Manufacturers of Steroids (corticosteroids) Table Applications of Multiple Myeloma Drugs Figure Global Consumption Volume Market Share of Multiple Myeloma Drugs by Application in 2017 Figure Men Examples Table Major Consumers in Men Figure Women Examples Table Major Consumers in Women Figure Market Share of Multiple Myeloma Drugs by Regions Figure North America Multiple Myeloma Drugs Market Size (Million USD) (2013-2025) Figure China Multiple Myeloma Drugs Market Size (Million USD) (2013-2025) Figure Europe Multiple Myeloma Drugs Market Size (Million USD) (2013-2025) Figure Southeast Asia Multiple Myeloma Drugs Market Size (Million USD) (2013-2025) Figure Japan Multiple Myeloma Drugs Market Size (Million USD) (2013-2025) Figure India Multiple Myeloma Drugs Market Size (Million USD) (2013-2025) Table Multiple Myeloma Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Multiple Myeloma Drugs in 2017 Figure Manufacturing Process Analysis of Multiple Myeloma Drugs Figure Industry Chain Structure of Multiple Myeloma Drugs Table Capacity and Commercial Production Date of Global Multiple Myeloma Drugs Major Manufacturers in 2017 Table Manufacturing Plants Distribution of Global Multiple Myeloma Drugs Major Manufacturers in 2017 Table R&D Status and Technology Source of Global Multiple Myeloma Drugs Major Manufacturers in 2017 Table Raw Materials Sources Analysis of Global Multiple Myeloma Drugs Major Manufacturers in 2017 Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Multiple Myeloma Drugs 2013-2018E Figure Global 2013-2018E Multiple Myeloma Drugs Market Size (Volume) and Growth Rate Figure Global 2013-2018E Multiple Myeloma Drugs Market Size (Value) and Growth Rate Table 2013-2018E Global Multiple Myeloma Drugs Capacity and Growth Rate Table 2017 Global Multiple Myeloma Drugs Capacity (K Units) List (Company Segment) Table 2013-2018E Global Multiple Myeloma Drugs Sales (K Units) and Growth Rate Table 2017 Global Multiple Myeloma Drugs Sales (K Units) List (Company Segment) Table 2013-2018E Global Multiple Myeloma Drugs Sales Price (USD/Unit) Table 2017 Global Multiple Myeloma Drugs Sales Price (USD/Unit) List (Company Segment) Figure North America Capacity Overview Table North America Supply, Import, Export and Consumption (K Units) of Multiple Myeloma Drugs 2013-2018E Figure North America 2013-2018E Multiple Myeloma Drugs Sales Price (USD/Unit) Figure North America 2017 Multiple Myeloma Drugs Sales Market Share Figure China Capacity Overview Table China Supply, Import, Export and Consumption (K Units) of Multiple Myeloma Drugs 2013-2018E Figure China 2013-2018E Multiple Myeloma Drugs Sales Price (USD/Unit) Figure China 2017 Multiple Myeloma Drugs Sales Market Share Figure Europe Capacity Overview Table Europe Supply, Import, Export and Consumption (K Units) of Multiple Myeloma Drugs 2013-2018E Figure Europe 2013-2018E Multiple Myeloma Drugs Sales Price (USD/Unit) Figure Europe 2017 Multiple Myeloma Drugs Sales Market Share Figure Southeast Asia Capacity Overview Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Multiple Myeloma Drugs 2013-2018E Figure Southeast Asia 2013-2018E Multiple Myeloma Drugs Sales Price (USD/Unit) Figure Southeast Asia 2017 Multiple Myeloma Drugs Sales Market Share Figure Japan Capacity Overview Table Japan Supply, Import, Export and Consumption (K Units) of Multiple Myeloma Drugs 2013-2018E Figure Japan 2013-2018E Multiple Myeloma Drugs Sales Price (USD/Unit) Figure Japan 2017 Multiple Myeloma Drugs Sales Market Share Figure India Capacity Overview Table India Supply, Import, Export and Consumption (K Units) of Multiple Myeloma Drugs 2013-2018E Figure India 2013-2018E Multiple Myeloma Drugs Sales Price (USD/Unit) Figure India 2017 Multiple Myeloma Drugs Sales Market Share Table Global 2013-2018E Multiple Myeloma Drugs Sales (K Units) by Type Table Different Types Multiple Myeloma Drugs Product Interview Price Table Global 2013-2018E Multiple Myeloma Drugs Sales (K Units) by Application Table Different Application Multiple Myeloma Drugs Product Interview Price Table Amgen Information List Table Product A Overview Table Product B Overview Table 2017 Amgen Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit) Figure 2017 Amgen Multiple Myeloma Drugs Business Region Distribution Table Johnson & Johnson Information List Table Product A Overview Table Product B Overview Table 2017 Johnson & Johnson Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit) Figure 2017 Johnson & Johnson Multiple Myeloma Drugs Business Region Distribution Table Celgene Information List Table Product A Overview Table Product B Overview Table 2015 Celgene Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit) Figure 2017 Celgene Multiple Myeloma Drugs Business Region Distribution Table Takeda Pharmaceutical Information List Table Product A Overview Table Product B Overview Table 2017 Takeda Pharmaceutical Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit) Figure 2017 Takeda Pharmaceutical Multiple Myeloma Drugs Business Region Distribution Table Novartis Information List Table Product A Overview Table Product B Overview Table 2017 Novartis Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit) Figure 2017 Novartis Multiple Myeloma Drugs Business Region Distribution Table Daiichi Sankyo Information List Table Product A Overview Table Product B Overview Table 2017 Daiichi Sankyo Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit) Figure 2017 Daiichi Sankyo Multiple Myeloma Drugs Business Region Distribution Table Merck Information List Table Product A Overview Table Product B Overview Table 2017 Merck Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit) Figure 2017 Merck Multiple Myeloma Drugs Business Region Distribution Table AB Science Information List Table Product A Overview Table Product B Overview Table 2017 AB Science Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit) Figure 2017 AB Science Multiple Myeloma Drugs Business Region Distribution Table Teva Information List Table Product A Overview Table Product B Overview Table 2017 Teva Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit) Figure 2017 Teva Multiple Myeloma Drugs Business Region Distribution Table PharmaMar Information List Table Product A Overview Table Product B Overview Table 2017 PharmaMar Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit) Figure 2017 PharmaMar Multiple Myeloma Drugs Business Region Distribution Figure Global 2018-2025 Multiple Myeloma Drugs Market Size (K Units) and Growth Rate Forecast Figure Global 2018-2025 Multiple Myeloma Drugs Market Size (Million USD) and Growth Rate Forecast Figure Global 2018-2025 Multiple Myeloma Drugs Sales Price (USD/Unit) Forecast Figure North America 2018-2025 Multiple Myeloma Drugs Consumption Volume (K Units) and Growth Rate Forecast Figure China 2018-2025 Multiple Myeloma Drugs Consumption Volume (K Units) and Growth Rate Forecast Figure Europe 2018-2025 Multiple Myeloma Drugs Consumption Volume (K Units) and Growth Rate Forecast Figure Southeast Asia 2018-2025 Multiple Myeloma Drugs Consumption Volume (K Units) and Growth Rate Forecast Figure Japan 2018-2025 Multiple Myeloma Drugs Consumption Volume (K Units) and Growth Rate Forecast Figure India 2018-2025 Multiple Myeloma Drugs Consumption Volume (K Units) and Growth Rate Forecast Table Global Sales Volume (K Units) of Multiple Myeloma Drugs by Type 2018-2025 Table Global Consumption Volume (K Units) of Multiple Myeloma Drugs by Application 2018-2025 Table Traders or Distributors with Contact Information of Multiple Myeloma Drugs by Region</pre>
Please submit the below form, to get more about this report:
Indicates required fields

Please fill your details below, to receive sample report:
Indicates required fields



Latest News

Jan-2018 |Electrical & Electronic

Study Claims That Mobile Apps Enhance Mental Health Thus Fueling The Global Smartphone Application Market

People undergoing mental health issues can reinforce their psychological well-being via mobile apps, a new survey claimed. The study, posted in the journal JMIR Mental Health, claimed that users who grapple with emotional and mental health issues ...

Jan-2018 |Medical & Health

Government Controlling Drugs And Prices Impacting Pharmaceuticals Market

The central government is preparing to curb the prices of combine drugs, which include 14 types of drugs. These drugs are used in the treatment of diseases such as high blood pressure, sugar, and cholesterol. The Nationa ...

Jan-2018 |ICT and Media

Two lakh Job In IT Sector Depicting Solid Growth In The Market

Last year, there was little interference for jobs in India but the scenario of jobs looks better in 2018. This year, there is hope for more than two lakh jobs in the information technology sector.

According to data, the Indian employment ...

Jan-2018 |Automobile

The Key Drivers Of The Automobile Market Are Tier-I, Iii Cities

The automobile industry despite various obstacles such as demonetization and GST has rapidly grabbed its momentum in this fiscal and has reported the growth of 9–10% compared to 7–8% in the last fiscal. This report was presented by Soc ...

Jan-2018 |Electrical & Electronic

Indian Smartphone Market Expected To Heat Up By Amazon With 10.or

Retailer Amazon is planning to introduce a smartphone range in the Indian market under a brand 10.or. This move is to take over the India-based rival, Flipkart.

The smartphones, which is expected to on sale on January 5 will be introduce ...